Vishal Manchanda
Vishal Manchanda is an analyst at Systematix Institutional Equities, where he focuses on the pharmaceutical sector. He has analyzed the pricing dynamics of weight-loss medications, predicting significant price corrections for Wegovy as generic versions enter the Indian market, which could greatly affect its accessibility for consumers.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Pakistan:
Vishal Manchanda is an analyst at Systematix Institutional Equities who expected significant price corrections for Wegovy once generics enter the market.
5